Targeting Recalcitrant Pathogens with Precision Medicine As we enter 2026, the scientific community is shifting away from broad spectrum antibiotics in favor of precision-guided antibacterial drugs. This transition is driven by the urgent need for antibiotic resistance management in clinical settings where traditional therapies have failed. Researchers are now utilizing CRISPR-based delivery...